| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.0008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |